Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01362647
Other study ID # B126201110617
Secondary ID IISP ID 39443
Status Completed
Phase N/A
First received May 25, 2011
Last updated October 4, 2011
Start date May 2011
Est. completion date October 2011

Study information

Verified date October 2011
Source Onze Lieve Vrouw Hospital
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Observational

Clinical Trial Summary

Several studies have documented that neuromuscular block often persists in the postanesthesia care unit (PACU). Residual paralysis is associated with postoperative complications such as hypoxia, weakness, and respiratory failure. The data in the current literature on residual paralysis in the PACU were almost exclusively obtained with acetylcholinesterase inhibitors as they were the only reversal agents available prior to the introduction in clinical practice of sugammadex (Bridion®) in the European Union and in some other countries, except for the USA. Reassessment of practice in this regard is relevant, now that sugammadex (Bridion®) has become available in our country since 2009.

This study is an observational/non-interventional, non-randomized study involving adult patients undergoing different types of elective surgical procedures requiring general anesthesia with neuromuscular blocking drugs (NMBDs). Administration of NMBDs and reversal agents (as well as all drugs which will be used during anesthesia) will be performed in accordance with routine anesthetic practice.

The study population will comprise about 600 surgical patients. Immediately after the patients' arrival in the PACU, a study nurse will record the acceleromyographic responses of their adductor pollicis muscle as percent of the train-of-four (TOF%) on stimulation of the ulnar nerve. A TOF of 90% will be used as cut-off value to exclude residual paralysis. Pulse oximetry (SpO2) will be measured continuously throughout the PACU admission, and SpO2 values will be recorded at 1-min intervals for the first 30 min. PACU nurses caring for the patient will document the occurrence of any of the following events during the first 30 min of PACU admission: the number of episodes of hypoxemia (SpO2<90%), the lowest SpO2 observed by nursing staff, the requirement for either tactile or verbal stimulation to maintain SpO2 greater than 90%, and any clinical evidence of airway obstruction.

The primary objective is to evaluate the incidence of postoperative residual curarisation at PACU arrival in patients reversed with sugammadex (Bridion®), neostigmine and in case of spontaneous recovery.

The secondary objectives are to evaluate:

- Oxygen saturation (SpO2) at PACU arrival

- Possible episodes of SpO2 <90% in the PACU

- Airway maneuvers and/or stimulation required to maintain SpO2 >90% in the PACU

- Need for re-intubation.


Description:

Read more »
Read more »

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
neuromuscular transmission monitoring
The acceleromyographic responses of the adductor pollicis muscle as percent of the train-of-four (TOF%) on stimulation of the ulnar nerve by means of TOF-Watch®, Organon Ireland Ltd., a division of MSD, Swords, Co., Dublin, Ireland.
Pulse oximetry measurement
Pulse oximetry will be measured continuously throughout the PACU admission, and SpO2 values will be recorded at 1-min intervals for the first 30 min.

Locations

Country Name City State
Belgium OLV Hospital Aalst

Sponsors (2)

Lead Sponsor Collaborator
Onze Lieve Vrouw Hospital Merck Sharp & Dohme Corp.

Country where clinical trial is conducted

Belgium, 

References & Publications (1)

Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, Vandenbroucke G, Deloof T. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg. 2006 Feb;102(2):426-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of postoperative residual curarisation incidence of postoperative residual curarisation (PORC) defined by a train-of-four (TOF) ratio < 0,9 at post-anesthesia care unit (PACU) arrival Immediately after the patients' arrival in the post-anesthesia care unit (<5 min after arrival), two consecutive neuromuscular transmission measurements (separated by 15 s) will be obtained, and the average of the 2 values will be recorded. Yes
Secondary Possible episodes of SpO2 <90% in the PACU During the first 30 min of PACU admission Yes
Secondary Airway maneuvers and/or stimulation required to maintain SpO2 >90% in the PACU the requirement for either tactile or verbal stimulation to maintain SpO2 greater than 90%, and any clinical evidence of airway obstruction During the first 30 min of PACU admission Yes
Secondary Need for re-intubation During the first 30 min of PACU admission Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06304493 - REMINDers for Incentive Spirometry in PACU (REMIND-IS in PACU) N/A
Completed NCT01887015 - Optiflow® to Prevent Post-Extubation Hypoxemia afteR Abdominal Surgery (the OPERA Trial) Phase 4
Not yet recruiting NCT05252234 - Post SARS-Cov-2 Disease Anesthesia Events